Managed by Henri and Jean-Frédéric Chibret, Laboratoires Théa is a major player in ophthalmology, with a presence in 70 countries around the world, more than 25 subsidiaries , and a turnover of over 500M€.
Now, Laboratoires Théa has created a new entity called Théa Open Innovation By putting in place license agreements and/or capital investments with partners, Théa Open Innovation brings:
- its expertise in ophthalmology development and the necessary funding to these partners to achieve proof of concept in humans
- and Laboratoires Théa’s ability to drive the regulatory phases of product development and commercialization.
Théa’s sustained success and innovation should be done along with staying true to our convictions. As a privately-held company, Théa can focus on long-term partnering and projects, not just short-term gains. We aim at developing new solutions for patients and practitioners in ophthalmology for a better quality of life.
We have to align our strategies, our priorities and our products with an ever-changing world. We believe that the future requires innovation, diversification, partnership and efficiency. But our mission and our values stay constant.
Small & medium-sized companies, start-ups, young innovative companies, researchers or academics can team up with Théa Open Innovation to offer tomorrow’s solutions to patients and eye-care practitioners.
N’hésitez pas à nous contacter pour nous soumettre vos idées et projets.